Interrelation between Expression of ADAM 10 and MMP 9 and Synthesis of Peroxynitrite in Doxorubicin Induced Cardiomyopathy.
- Author:
Sung Cil LIM
1
Author Information
1. The Catholic University of Korea College of Pharmacy, Bucheon 420-743, Republic of Korea. LIM5@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Doxorubicin;
Cardiomyopathy;
ADAM;
MMP
- MeSH:
Adult;
Animals;
Cardiomyopathies*;
Collagen;
Doxorubicin*;
Drug Therapy;
Drug-Related Side Effects and Adverse Reactions;
Echocardiography;
Heart Diseases;
Humans;
Immunohistochemistry;
Male;
Nitric Oxide;
Oxidative Stress;
Peroxynitrous Acid*;
Rats;
Rats, Sprague-Dawley;
Ventricular Remodeling
- From:Biomolecules & Therapeutics
2013;21(5):371-380
- CountryRepublic of Korea
- Language:English
-
Abstract:
Doxorubicin is still main drug in chemotherapy with limitation of use due to adverse drug reaction. Increased oxidative stress and alteration of nitric oxide control have been involved in cardiotoxicity of doxorubicin (DOX). A Disintegrin And Metalloproteinase (ADAMs) are transmembrane ectoproteases to regulate cell-cell and cell-matrix interactions, but role in cardiac disease is unclear. The aim of this study was to determine whether DOX activates peroxynitrite and ADAM 10 and thus ADAM and matrix metalloproteinase (MMP) induce cardiac remodeling in DOX-induced cardiomyopathy. Adult male Sprague-Dawley rats were subjected to cardiomyopathy by DOX (6 times of 2.5 mg/kg DOX over 2-weeks), and were randomized as four groups. Then followed by 3, 5, 7, and 14 days after cessation of DOX injection. DOX-injected animals significantly decreased left ventricular fractional shortening compared with control by M-mode echocardiography. The expressions of cardiac nitrotyrosine by immunohistochemistry were significant increased, and persisted for 2 weeks following the last injection. The expression of eNOS was increased by 1.9 times (p<0.05), and iNOS was marked increased in DOX-heart compared with control p<0.001). Compared to control rats, cardiac ADAM10- and MMP 9- protein expressions increased by 20 times, and active/total MMP 9 proteolytic activity showed increase tendency at day 14 after cessation of DOX injection (n=10, each group). DOX-treated H9C2 cell showed increased ADAM10 protein expression with dose-dependency p<0.01) and morphometric changes showed the increase of ventricular interstitial, nonvascular collagen deposition. These data suggest that activation of cardiac peroxynitrite with increased iNOS expression and ADAM 10-dependent MMP 9 expression may be a molecular mechanism that contributes to left ventricular remodeling in DOX-induced cardiomyopathy.
